ReviewInternational journal of molecular sciences2021

Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview.

Mohammad Enamul Hoque Kayesh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.